$ADPT Adaptive Biotechnologies Corp Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Adaptive Biotechnologies Corp.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Adaptive Biotechnologies Corp. Insider overview, share value development, latest insider transactions and email notifications about new events in Adaptive Biotechnologies Corp for free.

CIK Number: 0001478320
IRS Number: 270907024
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ADPT
Company Address: 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE 98102
Phone number: 206-659-0067
Former name: Adaptive TCR Corp, date of change: 2009-12-09

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.

Adaptive Biotechnologies Corp Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
BALDO LANCEChief Medical Officer00Feb 18 20201 month ago
BENZENO SHARONSVP, Drug Discovery00Feb 18 20201 month ago
BURRIS MICHELLEDirector00Feb 18 20201 month ago
Cohen Chad MChief Financial Officer21,0000shares bought: 41,000 / shares sold: -40,000 BUYFeb 18 20201 month ago
Conroy Kevin TDirector00Feb 18 20201 month ago
DOBMEIER ERICDirector15,0000shares bought: 15,000 / shares sold: -15,000 HOLDFeb 18 20201 month ago
GOEL DAVID E.Director15,115,0900shares bought: 17,332,191 / shares sold: -2,217,101 STRONG BUYJan 28 20202 months ago
HERSHBERG ROBERTDirector00Feb 18 20201 month ago
HILL NANCY LOUISESVP, Operations70,0000shares bought: 131,200 / shares sold: -120,000 BUYFeb 18 20201 month ago
LO FRANCISChief People Officer00Feb 18 20201 month ago
NEUPERT PETER MDirector00Feb 18 20201 month ago
Palaniappan JyotiSVP, Diagnostics, immunoSEQ Dx00Mar 23 20207 days ago
Pellini Michael JDirector00Feb 18 20201 month ago
ROBINS CHAD MCEO and Chairman1,889,3000shares bought: 174,080 / shares sold: -83,400 STRONG BUYMar 23 20207 days ago
ROBINS HARLAN SChief Scientific Officer78,0790shares bought: 89,179 / shares sold: -18,500 STRONG BUYFeb 24 20201 month ago
RUBINSTEIN JULIEPresident80,0000shares bought: 515,000 / shares sold: -515,000 HOLDFeb 24 20201 month ago
SANG CHARLESSVP, Clinical Diagnostics00Feb 18 20201 month ago
Taylor Stacy LSVP and General Counsel1,9620shares bought: 662 / shares sold: -662 HOLDFeb 18 20201 month ago
VIKING GLOBAL INVESTORS LP10% Owner33,493,7080shares bought: 36,981,607 / shares sold: -4,912,899 STRONG BUYJan 30 20202 months ago
VIKING GLOBAL PERFORMANCE LLC10% Owner33,493,7080shares bought: 0 / shares sold: -4,912,899 STRONG SELLJan 30 20202 months ago
ZOLTNERS ANDRIS ADirector3,966,0160shares bought: 3,966,016 / shares sold: -345,000 STRONG BUYFeb 18 20201 month ago

View all Adaptive Biotechnologies Corp insiders.

Adaptive Biotechnologies Corp Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 23 2020ADPTAdaptive Biotechno ...Palaniappan JyotiSVP, Diagnostics, i ...Option ExerciseA22.55125,0002,818,750125,000
Mar 23 2020ADPTAdaptive Biotechno ...ROBINS CHAD MCEO and ChairmanOption ExerciseM0.335,5601,835696,600
Mar 23 2020ADPTAdaptive Biotechno ...ROBINS CHAD MCEO and ChairmanOption ExerciseM0.3311,1203,670702,160
Mar 23 2020ADPTAdaptive Biotechno ...ROBINS CHAD MCEO and ChairmanSellS24.3888721,6251,878,1801.9 M to 1.9 M (-0.05 %)
Mar 23 2020ADPTAdaptive Biotechno ...ROBINS CHAD MCEO and ChairmanSellS23.5097322,8661,879,0671.9 M to 1.9 M (-0.05 %)
Mar 23 2020ADPTAdaptive Biotechno ...ROBINS CHAD MCEO and ChairmanSellS22.373,70082,7691,880,0401.9 M to 1.9 M (-0.20 %)
Mar 23 2020ADPTAdaptive Biotechno ...ROBINS CHAD MCEO and ChairmanBuyM0.335,5601,8351,883,7401.9 M to 1.9 M (+0.30 %)
Mar 23 2020ADPTAdaptive Biotechno ...ROBINS CHAD MCEO and ChairmanSellS22.3011,120247,9761,878,1801.9 M to 1.9 M (-0.59 %)
Mar 23 2020ADPTAdaptive Biotechno ...ROBINS CHAD MCEO and ChairmanBuyM0.3311,1203,6701,889,3001.9 M to 1.9 M (+0.59 %)
Feb 24 2020ADPTAdaptive Biotechno ...RUBINSTEIN JULIEPresidentOption ExerciseM0.845,0004,200220,000
Feb 24 2020ADPTAdaptive Biotechno ...RUBINSTEIN JULIEPresidentOption ExerciseM0.8480,00067,200225,000
Feb 24 2020ADPTAdaptive Biotechno ...RUBINSTEIN JULIEPresidentSellS33.555,000167,75005 K to 0 (-100.00 %)
Feb 24 2020ADPTAdaptive Biotechno ...RUBINSTEIN JULIEPresidentBuyM0.845,0004,2005,0000 to 5 K
Feb 24 2020ADPTAdaptive Biotechno ...RUBINSTEIN JULIEPresidentSellS34.0112,200414,922012.2 K to 0 (-100.00 %)
Feb 24 2020ADPTAdaptive Biotechno ...RUBINSTEIN JULIEPresidentSellS33.4967,8002,270,62212,20080 K to 12.2 K (-84.75 %)

View all Adaptive Biotechnologies Corp insider transactions.